Panic Disorders Market By Drug Class and Distribution Channel - Global Industry Analysis & Forecast to 2027
Published On : October 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC101452
Panic Disorders Market By Drug Class (Benzodiazepines, Anti-Depressants) Distribution Channel (Retail Pharmacies, E-Commerce, Hospital Pharmacies, Drug Stores) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Panic Disorders Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Panic disorder is a serious surge of anxiety and fear. It is intermittent, incapacitating and defined by its startling quality and weakening, immobilizing power. Signs incorporate nausea, trembling, heart palpitations, and shortness of breath, numbness, and others. Panic disorders may keep going for 5-10 minutes; however it can impact the person for a longer time. If treatment is neglected, panic disorders grow to agoraphobia. Panic disorders identified in patients who encounter unconstrained attacks and engrossed with the tension of a repeating panic disorder. Panic disorders generally show up in youths and once in a while witnessed in children's. Treatment incorporates medicinal treatment, psychological therapy, anxiety management therapies, and others.
Drivers and Restraints
The expanding awareness in regards to the disorders, developing predominance of the psychological and anxiety disorders, and the accessibility of treatment choices that are compelling are a portion of the key factors that gauge to fuel the development of the worldwide panic disorders market. The expanding activities that are being taken by the main players with the end goal to make a comprehension among the customers will quicken the development of the market. In the ongoing years, a few medications are in various periods of clinical trials, which will be popularized soon along these lines empowering the development of the market.
Regional Insights
North America is anticipated to reflect significant development in the upcoming years. The growth is owing to rising awareness of mental health in the region and increasing treatment options.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Sun Pharmaceuticals
- AstraZeneca
- Mylan
- Neurocrine Biosciences
- Eli Lilly and Company
- Sanofi
- Pfizer
- Boehringer Ingelheim
- Lundbeck
- AstraZeneca
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Panic Disorders Market, By Drug Class, Estimates and Forecast, 2017-2027 ($Million)
· Benzodiazepines
· Anti-Depressants
· Panic Disorders Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)
· Retail Pharmacies
· E-Commerce
· Hospital Pharmacies
· Drug Stores
· Panic Disorders Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
· North America
§ North America Panic Disorders Market, By Country
o U.S. Panic Disorders Market
o Canada Panic Disorders Market
o Mexico Panic Disorders Market
· Europe
§ Europe Panic Disorders Market, By Country
o Germany Panic Disorders Market
o UK Panic Disorders Market
o France Panic Disorders Market
o Russia Panic Disorders Market
o Italy Panic Disorders Market
o Rest of Europe Panic Disorders Market
· Asia-Pacific
§ Asia-Pacific Panic Disorders Market, By Country
o China Panic Disorders Market
o Japan Panic Disorders Market
o South Korea Panic Disorders Market
o India Panic Disorders Market
o Southeast Asia Panic Disorders Market
o Rest of Asia-Pacific Panic Disorders Market
· South America
§ South America Panic Disorders Market
o Brazil Panic Disorders Market
o Argentina Panic Disorders Market
o Columbia Panic Disorders Market
o Rest of South America Panic Disorders Market
· Middle East and Africa
§ Middle East and Africa Panic Disorders Market
o Saudi Arabia Panic Disorders Market
o UAE Panic Disorders Market
o Egypt Panic Disorders Market
o Nigeria Panic Disorders Market
o South Africa Panic Disorders Market
o Rest of MEA Panic Disorders Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Panic Disorders Market, By Drug Class
5.1. Introduction
5.2. Global Panic Disorders Revenue and Market Share by Drug Class (2017-2027)
5.2.1. Global Panic Disorders Revenue and Revenue Share by Drug Class (2017-2027)
5.3. Benzodiazepines
5.3.1. Global Benzodiazepines Revenue and Growth Rate (2017-2027)
5.4. Anti-Depressants
5.4.1. Global Anti-Depressants Revenue and Growth Rate (2017-2027)
6. Panic Disorders Market, By Distribution Channel
6.1. Introduction
6.2. Global Panic Disorders Revenue and Market Share by Distribution Channel (2017-2027)
6.2.1. Global Panic Disorders Revenue and Revenue Share by Distribution Channel (2017-2027)
6.3. Retail Pharmacies
6.3.1. Global Retail Pharmacies Revenue and Growth Rate (2017-2027)
6.4. E-Commerce
6.4.1. Global E-Commerce Revenue and Growth Rate (2017-2027)
6.5. Hospital Pharmacies
6.5.1. Global Hospital Pharmacies Revenue and Growth Rate (2017-2027)
6.6. Drug Stores
6.6.1. Global Drug Stores Revenue and Growth Rate (2017-2027)
7. Panic Disorders Market, By Region
7.1. Introduction
7.2. Global Panic Disorders Revenue and Market Share by Regions
7.2.1. Global Panic Disorders Revenue by Regions (2017-2027)
7.3. North America Panic Disorders by Countries
7.3.1. North America Panic Disorders Revenue and Growth Rate (2017-2027)
7.3.2. North America Panic Disorders Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Panic Disorders by Countries
7.4.1. Europe Panic Disorders Revenue and Growth Rate (2017-2027)
7.4.2. Europe Panic Disorders Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Panic Disorders by Countries
7.5.1. Asia-Pacific Panic Disorders Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Panic Disorders Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Panic Disorders by Countries
7.6.1. South America Panic Disorders Revenue and Growth Rate (2017-2027)
7.6.2. South America Panic Disorders Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Panic Disorders by Countries
7.7.1. Middle East and Africa Panic Disorders Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Panic Disorders Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Sun Pharmaceuticals
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Revenue and Market Share
8.2. AstraZeneca
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Revenue and Market Share
8.3. Mylan
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Revenue and Market Share
8.4. Neurocrine Biosciences
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Revenue and Market Share
8.5. Eli Lilly and Company
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Revenue and Market Share
8.6. Sanofi
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Revenue and Market Share
8.7. Pfizer
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Revenue and Market Share
8.8. Boehringer Ingelheim
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Revenue and Market Share
8.9. Lundbeck
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Revenue and Market Share
8.10. AstraZeneca
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Revenue and Market Share
9. Global Panic Disorders Market Competition, by Manufacturer
9.1. Global Panic Disorders Revenue and Market Share by Manufacturer (2017-2017)
9.2. Global Panic Disorders Price By Region (2017-2017)
9.3. Top 5 Panic Disorders Manufacturer Market Share
9.4. Market Competition Trend
10. Panic Disorders Market Forecast (2017-2027)
10.1. Global Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Panic Disorders Market Forecast by Regions (2017-2027)
10.2.1. North America Panic Disorders Market Forecast (2017-2027)
10.2.1.1. United States Panic Disorders Market Forecast (2017-2027)
10.2.1.2. Canada Panic Disorders Market Forecast (2017-2027)
10.2.1.3. Mexico Panic Disorders Market Forecast (2017-2027)
10.2.2. Europe Panic Disorders Market Forecast (2017-2027)
10.2.2.1. Germany Panic Disorders Market Forecast (2017-2027)
10.2.2.2. France Panic Disorders Market Forecast (2017-2027)
10.2.2.3. UK Panic Disorders Market Forecast (2017-2027)
10.2.2.4. Russia Panic Disorders Market Forecast (2017-2027)
10.2.2.5. Italy Panic Disorders Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Panic Disorders Market Forecast (2017-2027)
10.2.3. Asia-Pacific Panic Disorders Market Forecast (2017-2027)
10.2.3.1. China Panic Disorders Market Forecast (2017-2027)
10.2.3.2. Japan Panic Disorders Market Forecast (2017-2027)
10.2.3.3. Korea Panic Disorders Market Forecast (2017-2027)
10.2.3.4. India Panic Disorders Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Panic Disorders Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Panic Disorders Market Forecast (2017-2027)
10.2.4. South America Panic Disorders Market Forecast (2017-2027)
10.2.4.1. Brazil Panic Disorders Market Forecast (2017-2027)
10.2.4.2. Argentina Panic Disorders Market Forecast (2017-2027)
10.2.4.3. Columbia Panic Disorders Market Forecast (2017-2027)
10.2.4.4. Rest of South America Panic Disorders Market Forecast (2017-2027)
10.2.5. Middle East and Africa Panic Disorders Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Panic Disorders Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Panic Disorders Market Forecast (2017-2027)
10.2.5.3. Egypt Panic Disorders Market Forecast (2017-2027)
10.2.5.4. Nigeria Panic Disorders Market Forecast (2017-2027)
10.2.5.5. South Africa Panic Disorders Market Forecast (2017-2027)
10.2.5.6. Turkey Panic Disorders Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Panic Disorders Market Forecast (2017-2027)
10.3. Panic Disorders Market Forecast by Drug Class (2017-2027)
10.3.1. Panic Disorders Forecast by Drug Class (2017-2027)
10.3.2. Panic Disorders Market Share Forecast by Drug Class (2017-2027)
10.4. Panic Disorders Market Forecast by Distribution Channel (2017-2027)
10.4.1. Panic Disorders Forecast by Distribution Channel (2017-2027)
10.4.2. Panic Disorders Market Share Forecast by Distribution Channel (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Panic Disorders Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Panic Disorders Revenue and Revenue Share by Drug Class (2017-2018)
Figure Global Benzodiazepines Revenue and Growth Rate (2017-2018)
Figure Global Anti-Depressants Revenue and Growth Rate (2017-2018)
Table Global Panic Disorders Revenue and Revenue Share by Distribution Channel (2017-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global E-Commerce Revenue and Growth Rate (2017-2018)
Figure Global Hospital Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Drug Stores Revenue and Growth Rate (2017-2018)
Table Global Panic Disorders Revenue by Regions (2017-2018)
Figure North America Panic Disorders Growth Rate (2017-2018)
Figure North America Panic Disorders Revenue and Growth Rate (2017-2018)
Figure North America Panic Disorders by Countries (2017-2018)
Figure North America Panic Disorders Revenue (Million USD) by Countries (2017-2018)
Figure United States Panic Disorders Growth Rate (2017-2018)
Figure United States Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Panic Disorders Growth Rate (2017-2018)
Figure Canada Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Panic Disorders Growth Rate (2017-2018)
Figure Mexico Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Panic Disorders Growth Rate (2017-2018)
Figure Europe Panic Disorders Revenue and Growth Rate (2017-2018)
Figure Europe Panic Disorders by Countries (2017-2018)
Figure Europe Panic Disorders Revenue (Million USD) by Countries (2017-2018)
Figure Germany Panic Disorders Growth Rate (2017-2018)
Figure Germany Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Panic Disorders Growth Rate (2017-2018)
Figure France Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Panic Disorders Growth Rate (2017-2018)
Figure UK Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Panic Disorders Growth Rate (2017-2018)
Figure Russia Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Panic Disorders Growth Rate (2017-2018)
Figure Italy Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Panic Disorders Growth Rate (2017-2018)
Figure Rest of Europe Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Panic Disorders Growth Rate (2017-2018)
Figure Asia-Pacific Panic Disorders Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Panic Disorders by Countries (2017-2018)
Figure Asia-Pacific Panic Disorders Revenue (Million USD) by Countries (2017-2018)
Figure China Panic Disorders Growth Rate (2017-2018)
Figure China Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Panic Disorders Growth Rate (2017-2018)
Figure Japan Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Panic Disorders Growth Rate (2017-2018)
Figure Korea Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Panic Disorders Growth Rate (2017-2018)
Figure India Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Panic Disorders Growth Rate (2017-2018)
Figure Southeast Asia Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Panic Disorders Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Panic Disorders Growth Rate (2017-2018)
Figure South America Panic Disorders Revenue and Growth Rate (2017-2018)
Figure South America Panic Disorders by Countries (2017-2018)
Figure South America Panic Disorders Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Panic Disorders Growth Rate (2017-2018)
Figure Brazil Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Panic Disorders Growth Rate (2017-2018)
Figure Argentina Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Panic Disorders Growth Rate (2017-2018)
Figure Columbia Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Panic Disorders Growth Rate (2017-2018)
Figure Rest of South America Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Panic Disorders Growth Rate (2017-2018)
Figure Middle East and Africa Panic Disorders Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Panic Disorders by Countries (2017-2018)
Figure Middle East and Africa Panic Disorders Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Panic Disorders Growth Rate (2017-2018)
Figure Saudi Arabia Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Panic Disorders Growth Rate (2017-2018)
Figure United Arab Emirates Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Panic Disorders Growth Rate (2017-2018)
Figure Egypt Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Panic Disorders Growth Rate (2017-2018)
Figure Nigeria Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Panic Disorders Growth Rate (2017-2018)
Figure South Africa Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Panic Disorders Growth Rate (2017-2018)
Figure Turkey Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Panic Disorders Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Panic Disorders Revenue (Millions USD) and Growth Rate (2017-2018)
Table Sun Pharmaceuticals Panic Disorders Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AstraZeneca Panic Disorders Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mylan Panic Disorders Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Neurocrine Biosciences Panic Disorders Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Eli Lilly and Company Panic Disorders Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi Panic Disorders Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Panic Disorders Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Boehringer Ingelheim Panic Disorders Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Lundbeck Panic Disorders Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AstraZeneca Panic Disorders Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Panic Disorders Market Share by Manufacturer
Figure Global Panic Disorders Revenue and Market Share by Manufacturer
Table Global Panic Disorders Price by Region (2017-2017)
Figure Top 5 Panic Disorders Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Panic Disorders Revenue (Millions USD) and Growth Rate (2018-2025)
Table Panic Disorders Market Forecast by Regions (2018-2025)
Figure North America Panic Disorders Market Forecast (2018-2025)
Figure United States Panic Disorders Market Forecast (2018-2025)
Figure Canada Panic Disorders Market Forecast (2018-2025)
Figure Mexico Panic Disorders Market Forecast (2018-2025)
Figure Europe Panic Disorders Market Forecast (2018-2025)
Figure Germany Panic Disorders Market Forecast (2018-2025)
Figure France Panic Disorders Market Forecast (2018-2025)
Figure UK Panic Disorders Market Forecast (2018-2025)
Figure Russia Panic Disorders Market Forecast (2018-2025)
Figure Italy Panic Disorders Market Forecast (2018-2025)
Figure Rest of Europe Panic Disorders Market Forecast (2018-2025)
Figure Asia-Pacific Panic Disorders Market Forecast (2018-2025)
Figure China Panic Disorders Market Forecast (2018-2025)
Figure Japan Panic Disorders Market Forecast (2018-2025)
Figure Korea Panic Disorders Market Forecast (2018-2025)
Figure India Panic Disorders Market Forecast (2018-2025)
Figure Southeast Asia Panic Disorders Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Panic Disorders Market Forecast (2018-2025)
Figure South America Panic Disorders Market Forecast (2018-2025)
Figure Brazil Panic Disorders Market Forecast (2018-2025)
Figure Argentina Panic Disorders Market Forecast (2018-2025)
Figure Columbia Panic Disorders Market Forecast (2018-2025)
Figure Rest of South America Panic Disorders Market Forecast (2018-2025)
Figure Middle East and Africa Panic Disorders Market Forecast (2018-2025)
Figure Saudi Arabia Panic Disorders Market Forecast (2018-2025)
Figure United Arab Emirates Panic Disorders Market Forecast (2018-2025)
Figure Egypt Panic Disorders Market Forecast (2018-2025)
Figure Nigeria Panic Disorders Market Forecast (2018-2025)
Figure South Africa Panic Disorders Market Forecast (2018-2025)
Figure Turkey Panic Disorders Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Panic Disorders Market Forecast (2018-2025)
Figure Global Panic Disorders Forecast by Drug Class (2018-2025)
Figure Global Panic Disorders Market Share Forecast by Drug Class (2018-2025)
Figure Global Panic Disorders Forecast by Drug Class (2018-2025)
Figure Global Panic Disorders Forecast by Distribution Channel (2018-2025)
Figure Global Panic Disorders Market Share Forecast by Distribution Channel (2018-2025)
Figure Global Panic Disorders Forecast by Distribution Channel (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|